Psilocybin made human cells live 50% longer.
A new study has uncovered surprising anti-aging potential in psilocin—the active metabolite produced when the body breaks down psilocybin, the psychoactive compound found in magic mushrooms.
In laboratory experiments, researchers exposed two human cell lines (skin fibroblasts and fetal lung fibroblasts) to a 100 μM concentration of psilocin. The results were striking: lung cells took 57% longer to reach replicative senescence (the point at which cells permanently stop dividing and accumulate damage), while skin fibroblasts extended their replicative lifespan by 51%.
These findings suggest psilocin may slow fundamental cellular aging processes, possibly by lowering oxidative stress, enhancing DNA-repair pathways, supporting mitochondrial health, or dampening chronic inflammation—mechanisms that overlap with those targeted by leading experimental longevity drugs.
The benefits extended beyond cell culture. In aged female mice (19 months old at the start, equivalent to approximately 60–65 human years), a single monthly dose of psilocybin dramatically improved outcomes. After 10 months of treatment, 80% of the psilocybin-treated animals remained alive, compared with only 50% of untreated controls. Treated mice also displayed markedly fewer visible signs of aging, including reduced fur loss and graying.
This research marks the first direct demonstration that psilocybin/psilocin can influence biological aging itself, rather than solely producing psychological effects. The authors emphasize that the study used relatively conservative dosing and are now advocating for follow-up work with higher or more frequent administration, detailed assessments of immune, metabolic, and cognitive function, and investigations into whether the extended lifespan corresponds to genuine improvements in healthspan and quality of life.
["Psilocybin treatment extends cellular lifespan and improves survival of aged mice." npj Aging, 2025]
We delve into the mechanisms behind psilocybin's effects on healthspan, findings from animal studies, and the challenges faced in conducting research on this Schedule I substance.
Watch the full episode with Dr. @HeckerLouise:
https://t.co/omfRmLCEOW
#psilocybin#longevity
This week, Dr. @HeckerLouise joins us to discuss her groundbreaking research on psilocybin, exploring its potential to extend cellular lifespan and improve health outcomes in aging.
Watch the full episode now:
https://t.co/omfRmLCEOW
#psilocybin#psilocybintherapy#longevity
🧬 BIG news for Anti Aging inventions.
🍄 Mushroom drug might slow fundamental aging processes.
Psilocybin’s active metabolite kept human fibroblast cultures alive 29% longer at 10 µM and 57% longer at 100 µM.
Aged mice given monthly psilocybin showed 80% survival, while only 50% of control animals made it through the same 10-month span.
Psilocybin has long been tested for depression and addiction, yet many researchers suspected a deeper link between the compound and biological aging because positive mental states often track with longer telomeres, the protective DNA caps that shrink as cells age.
The current team put that idea on the bench by switching to a standard replicative-senescence model that forces fibroblasts to divide until they quit.
The authors close by framing psilocybin as a possible full-body anti-aging drug that tackles senescence, telomere erosion, oxidative stress, and DNA stability in one shot, while calling for longer studies to rule out late cancer risks and to fine-tune dose and timing.
If these findings hold up across sexes, species, and longer lifespans, the compound could join the small club of agents that extend healthy years rather than just treat age-linked symptoms.
Still struck by the dramatic effects of psilocybin on mouse health & lifespan 🍄🟫
Here’s some info about this molecule & where people obtain it: 🧵…
Full video version of my conversation with Dr. Louise Hecker.
We cover her new study on how psilocybin affects aging in mice, plus a more general discussion of oxidative stress, scarring, and fibrosis.
Forget Botox...
Scientists say tripping on mushrooms might keep you young.
Mice treated with psilocybin lived longer and had healthier fur, fewer gray hairs, and more hair regrowth.
https://t.co/ezULuf0MgS
Crazy Anti Aging Discovery
A new study from Emory University reveals that psilocin, the active metabolite of psilocybin (from psychedelic mushrooms), can delay cellular aging and extend lifespan. 👀
Human cells lived over 50% longer, and mice treated with psilocybin lived 30% longer, with improved physical aging signs like fur quality and hair regrowth.
The research suggests psilocybin enhances DNA repair, reduces oxidative stress, and preserves telomeres - key factors in aging.
This breakthrough points to psilocybin’s potential as a powerful anti aging therapy, beyond its known mental health benefits.
As revenues from the anti-aging market surged past $500 million last year, Emory University researchers identified a compound that actively delays aging in cells and organisms. 🔗 Study results: https://t.co/wnINIpmyNs #EmoryUniversity#Emory#Psilocybin
Can psilocybin slow aging? 🧬🍄 I spoke with Dr. Louise Hecker about her new study showing it extended lifespan in mice. We dive into the science + what it means for human health.
🎧 Watch it here: https://t.co/0NJuONaaET
#Psilocybin#Longevity#FoodiePharmacology
🚨🇺🇸 PSILOCYBIN MAKES HUMAN CELLS LIVE 50% LONGER, STUDY SHOWS
Researchers at Emory and Baylor just dropped a bombshell: psilocybin, the magic in magic mushrooms, slowed cellular aging in both human cells and mice.
Lung and skin cells treated with psilocin (what psilocybin turns into in your body) took over 50% longer to hit senescence, the stage where cells stop dividing and go full grandma mode.
In live trials, 80% of elderly mice dosed monthly with psilocybin were still alive after 10 months. The control group? Just 50%.
Even the mice looked better - less fur loss, fewer gray hairs, more energy.
Scientists say it’s the first real evidence that psychedelics might not just heal minds… but stretch lifespans too.
Source: Science Alert
Psychedelics used to be so edgy to talk about. Now, federal tax $ is used to study their effects in mice & there are human clinical trials completed & ongoing. People are discussing psilocybin for longevity. MDMA & ibogaine likely to gain FDA approval soon. Things. Have. Changed.
Psilocybin shows potential as an anti-aging molecule, with lifespan-enhancing results in human cells and mice observed in a new study.
In vitro, psilocin (psilocybin’s metabolite) extended cellular lifespan by 29% at baseline and 57% at higher doses. It also reduced markers of aging like β-gal activity, boosted sirtuin (SIRT1) levels, lowered DNA damage and oxidative stress, and preserved telomeres.
In vivo, 19-month-old female mice (equivalent to ~60–65 human years) who received monthly psilocybin doses for 10 months had 80% survival vs. 50% in controls. Treated mice also appeared younger—with improved fur quality, more hair growth, and less graying.
Although psilocybin is listed as a Schedule I substance, these findings position it as a novel therapy for healthy aging and open a path toward 'psychedelic-assisted senotherapeutics', interventions that may enhance psychological well-being while also slowing genetic aging.
No matter your stance on psychedelics, these findings should intrigue you.